These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23735341)

  • 1. A comparison of non-HDL and LDL cholesterol goal attainment in the CHILLAS trial.
    Yu BL; Zhao SP; Peng DQ; Huo Y; Hu L
    Int J Cardiol; 2013 Oct; 168(4):4340-2. PubMed ID: 23735341
    [No Abstract]   [Full Text] [Related]  

  • 2. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins in dyslipidemia associated with acute myocardial infarct].
    Smajić E; Kusljugić Z; Baraković F; Divković K; Hukić-Suljkanović N; Mrsić D; Hujdurović S
    Med Arh; 2004; 58(2 Suppl 1):21-3. PubMed ID: 15202301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
    Higashikata T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and tolerability of statins in patients with primary hyperlipidemias].
    Rozhkova TA; Susekov AV; Solov'eva EIu; Titov VN; Kukharchuk VV
    Kardiologiia; 2005; 45(9):32-4. PubMed ID: 16234790
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.
    Soran H; France MW; Kwok S; Dissanayake S; Charlton-Menys V; Younis NN; Durrington PN
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):566-71. PubMed ID: 22006975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national study on lipid management.
    Jotkowitz AB; Novack V; Rabinowitz G; Segal AR; Weitzman R; Porath A
    Eur J Intern Med; 2008 Jul; 19(5):356-61. PubMed ID: 18549939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of dyslipidemia.
    Kashyap M
    Manag Care; 2001 Nov; 10(11 Suppl):4-9; discussion 19-24. PubMed ID: 11761628
    [No Abstract]   [Full Text] [Related]  

  • 10. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary of the role of statins in the treatment of dyslipidemia.
    Carr LL
    J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S1-3. PubMed ID: 12884937
    [No Abstract]   [Full Text] [Related]  

  • 13. New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention.
    Anderson TJ
    Can J Cardiol; 2015 May; 31(5):585-7. PubMed ID: 25936485
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
    Virani SS; Ballantyne CM
    Curr Opin Lipidol; 2010 Apr; 21(2):165-6. PubMed ID: 20616632
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
    Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipidemia in patients with ischemic heart disease].
    Murase T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():722-7. PubMed ID: 11347161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
    [No Abstract]   [Full Text] [Related]  

  • 20. Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.
    Idris I; Tate H; Ahmad A; McCormack T
    J Clin Lipidol; 2011; 5(4):316-23. PubMed ID: 21784378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.